NCT03299608 Rapid Analysis of Infections by Spectrometry of Exhaled Breath
| NCT ID | NCT03299608 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitaire Ziekenhuizen KU Leuven |
| Condition | Respiratory Tract Infections |
| Study Type | OBSERVATIONAL |
| Enrollment | 246 participants |
| Start Date | 2019-06-21 |
| Primary Completion | 2025-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 246 participants in total. It began in 2019-06-21 with a primary completion date of 2025-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To quantify the diagnostic, prognostic and therapeutic value of spectrometric analysis of exhaled breath from hematological patients with respiratory infection.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18y at start of study * One of the following diagnoses: * De novo, refractory or relapsed AML/MDS receiving intensive chemotherapy * De novo, refractory or relapsed ALL/T-lymphoblastic lymphoma receiving intensive chemotherapy * Aplastic anemia requiring ATG therapy * Any patient admitted for either autologous hematopoietic stem cell transplantation. Transplantation may not have been performed at time of enrolment. * Any patient admitted with allogeneic hematopoietic stem cell transplantation within the last year, or planned during this admission. * Written informed consent obtained from the patient Exclusion Criteria: * Hematological disease beyond the specified inclusion criteria * Signs of active respiratory infection * If previously enrolled: incomplete clearance of all signs of respiratory infection (both clinically, microbiologically and radiologically).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT03299608 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Respiratory Tract Infections. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03299608 currently recruiting?
Yes, NCT03299608 is actively recruiting participants. Contact the research team at toine.mercier@uzleuven.be for enrollment information.
Where is the NCT03299608 trial being conducted?
This trial is being conducted at Leuven, Belgium.
Who is sponsoring the NCT03299608 clinical trial?
NCT03299608 is sponsored by Universitaire Ziekenhuizen KU Leuven. The trial plans to enroll 246 participants.